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In recent years, the thioisatin (benzo[b]thiophene-2,3-diones) have attracted considerable attention due to their ability to 
act as intermediates in the preparation of a series of fused spiroheterocycles. The benzothiophenic frameworks are important 
targets in synthetic and medicinal chemistry because this fragment is a key moiety in a wide number of natural and synthetic 
agents. Subsequently the present study deals with the synthesis of a variety of spiroheterocycles for which different 
strategies have been evolved viz. [4+2] photocycloaddition (spiropyrans), cyclocondensation (benzodiazocine), nucleophilic 
cyclization (spirothioazolidinones) and air oxidation (disulfides). semicarbazide reacts with thioisatin at 3-position 
(thiosemicarbazones, 2-hydroxy-(2H)-3,3-diaryl- and 3-hydroxy-3H-2,2-diaryl-benzo[b]thiophenes hydroxyl compounds), 
4,9-dimethylthiophanthrenes. 
Keywords: Thioisatin, reactivity of β-carbonyl functionality, disulfides derivatives, photocycloaddition reactions 
The synthesis of privileged classes of heterocyclic 
compounds has become one of the prime areas of 
research in the field of synthetic and medicinal 
chemistry. Most of the compounds participate in 
important biochemical processes and are the 
constituents of main substances (DNA, RNA) in 
living cells. For more than a century, heterocyclic 
compounds have ranked amongest the most important 
compounds and the fused heterocyclic ring systems 
have emerged as the important scaffolds’ in medicinal 
chemistry1 and appear in several natural and synthetic 
compounds of significant pharmacological properties2. 
In recent years, the benzo[b]thiophene-2,3-diones 
have attracted considerable attention due to their 
ability to act as intermediates in the preparation of a 
series of fused benzothiazolidinones3. Benzothiophene 
frameworks is a core structure in the most popular 
commercial drugs4 i.e. Sertaconazole (Dermofix), 
Raloxifine (Evista), Metizoline, etc. In Sertaconazole 
benzothiophene ring mimics tryptophan ( that is found 
in the fungal membrane in addition to lipid) and 
increases the drugs ability to form the pores in the 
fungal cell membranes. Raloxifeine (Evista) is used in 
the prevention of osteoporosis in postmenopausal 
women5. Raloxifene caused fewer uterine cancers as 
was announced by “National Cancer Institute’’ in 
2006. Metizoline is used as a vasoconstrictus and 
nasal decongestant drug. 
Amongst the various fused heterocycles, thiophene 
moieties fused with benzene ring viz. thioisatin  
or benzo[b]thiophene-2,3-diones (Figure 1) have 
important applications in synthetic organic 
chemistry6-10. 
For the preparation of thioisatin or 
benzo[b]thiophene-2,3-dione, thiophenol (1a) was 
reacted with oxalyl chloride in refluxing diethyl ether. 
This is followed by intramolecular Friedel Crafts 
cyclisation of the intermediate acyl chloride (2) with 
AlCl3 to afford the benzo[b]thiophene-2,3-dione 
(thioisatin) (Scheme I) in 75% yield. 
Figure 1 — Benzo[b]thiophene-2,3-diones 




5-Methylbenzo[b]thiophene-2, 3-dione (5-methyl 
thioisatin) was also prepared by the similar procedure 
using 4-methylthiophenol and oxalyl chloride in 69% 
yield. The crude products were purified by column 
chromatography over silica gel wherein shiny reddish 
and orange crystals were obtained from petroleum 
ether-chloroform (4:1) as eluent fraction. 
The IR spectrum of thioisatin (1a) showed 
absorption peak at 3100 for C-H aromatic, 2890 for 
C-H aliphatic, 1730 and 1710 for S–C=O and >C=O 
respectively and a peak at 675 cm–1 was assigned to 
C-S vibrations. In the 1H NMR spectrum, signal for 5-
H and 6-H resonated at  7.20-7.33 ppm as multiplet  
and a double doublet was observed for 7-H at  7.55  
(J1 = 7.0 Hz, J2 = 1.5 Hz). A doublet was obtained  
for 4-H at  7.71 (J = 7.4 Hz). 
In case of 5-methylthioisatin (1b) its IR spectrum 
showed following absorption peaks: 1734 and  
1707 cm−1 (νC=O), 690 cm−1 (νC-S) vibrations. In the  
1H NMR, methyl protons showed a singlet at  2.314 
and a doublet was observed for 6-H at  7.42  
(J = 8.1 Hz). The 4-H proton and 7-H protons 
resonated as doublets at  7.59 (J = 7.2 Hz) and  
 7.70 ppm (J = 6.2 Hz) respectively. In 13C NMR 
spectrum the two carbonyl carbons resonated at  
 186.79 ppm (2-C=O) and  182.51 ppm (3-C=O) 
respectively. Other signals obtained are: aromatic 
carbons (C-7a) at  139.78, (C-4) at  139.14, (C-3a) 
at  138.46, (C-7) at  129.09, (C-6) at  125.63, (C-
5) at  124.92 and methyl carbon resonated at  21.28 
ppm. Its mass spectrum showed molecular ion peak 
(M+) at m/z 177.9 (15%) which produced a base peak 
at m/z 149.9 [100%] by loss of CO moiety as depicted 
in Scheme II. 
The C-3 carbonyl group of benzo[b]thiophene-2,3-
dione (thioisatin) is strongly electrophilic11. 
Thioisatin, is briefly reported in condensation  
and addition reactions12. To widen the scope,  
we have synthesized novel compounds from  
thioisatin and its derivatives viz. spiropyrans, 
8-membered benzodiazocines, thiazolidinones and 
diphenyldisulfides. In most of these reactions, 
chalcones act as intermediates and can inhibit 
glutathione-S-transferases (GSTs) enzymes that 
appear to be involved in drug resistance13 and it also 
seems to be promising antifungal drug and may 
inhibit the growth of various fungi and yeast14. 
Spiropyran heterocyclics are of considerable interest 
because the conformational restriction associated with 
the structural rigidity influences considerably their 
biological activity15. Therefore the spiropyrans 
structural system is also a core skeleton of  
many bioactive natural products such as cytotoxic 
rotenoid amorphispironone, antimalarials, robustadials 
and antileishmanial euglobals16,17. Synthetic 
spirobenzopyranes, such as sorbinil and SNK-860, 
have been shown to be potent aldose reductase 
inhibitors18 and hence reported synthesis may be 
potentially useful to prevent long-term diabetic 
complications. Several benzodiazocine derivatives 
have been shown to be pharmacologically useful such 
as antiviral, cholesterol-lowering and hormone-like 
activity19-22. Additionally some members of diazocine 
system have found applications as homologues of 
benzodiazepine drugs and as reversal agents in 
multidrug resistance23-25. In recent years material 
chemists have explored the electrochemical properties 
of diazocines, which were found to be useful as a basis 
for molecular machines and artificial muscles26,27. 
The disulfides have emerged as a valuable tool in 
biochemistry, medicinal and biological chemistry due 
to their selective formation in the presence of other 
functional groups and reversibility of their formation 
under reducing conditions28. Hence, disulfide bond 
formation has been used for facilitating protein 
refolding and for the synthesis of prodrugs with 
increased hydrophobicity or cell permeability29. Inside 
the cell the disulfide bond is then conveniently 
reduced as a result of the high glutathione levels, thus 
releasing the active compounds30-32. 
It is evident from the above discussion that 
synthesized scaffolds may play a crucial role in search 
for new pharmacological agents and drugs and hence 
a detailed methodology, application and reactivity of 
analogues of synthesized heterocyclic motif’s is 





Scheme II — Mass fragmentation pattern of 5-methylthioisatin 




Synthesis and reactions of thioisatin derivatives: 
reactivity of β- carbonyl functionality 
i. Thioisatin react with hydrazines to give 
hydrazones (2) with the condensation taking place 
at the β-carbonyl33,34. Similarly thiosemicarbazides 
and semicarbazides reacts with thioisatin at 
3-position to give thiosemicarbazones (3). 
Hydroxlyamines35 and N-methylhydroxylamines 
afford (4) and (5) respectively. 
ii. A novel synthesis of phosphoanylidene-
cyclobutane diones (6) and dithioxo 
cyclobutylidenes (7) from the reaction of  
Ph3P+C- C-X with benzo[b]thiophene-2,  
3-diones has been reported36. The reaction of 
stabilized 2-oxoalkylidene phosphoranes, eg., 
Ph3P:CHCOMe, and unsaturated ketone (8) was 
also studied. 
iii. The synthesis a few 2-hydroxy-(2H)-3, 3-diaryl- 
and 3-hydroxy-3H-2,2-diaryl-benzo[b]thiophenes 
hydroxyl compounds is described37. By acidic 
treatement these compounds readily rearrange to 
2,3-diaryl-benzo[b]thiophenes in almost 
quantitative yields (Scheme III). 
iv. Thioisatin was caused to react with ω-
chloroacetophenone, 1-bromoacetyl- or 2-
bromoacetylnaphthalene in alkaline solution 
followed by cyclization of the intermediate  








converted to the corresponding 4,9-
dimethylthiophanthrenes (9)38. 
i. The use of 2,3-dihydrobenzo[b]thiophene-2, 3-
dione as a source of 2-mercaptophenylacetic  
acid permits a convenient preparation of  
2-carboxymethyl thiophenyl acetic acid or 
derivatives. These undergo a Dieckmann 
cyclization to 3-acetoxybenzothiopyrans which 
may be hydrolysed to thiochroman-3-ones 
(Scheme IV)39. 
ii. Benzothiet-2-one is obtained as a neat solid, 
stable below −20°C (−45°C in solution), by flash 
vaccum pyrolysis of benzothiophene-2,3-dione. 
The thietones undergo rapid ring opening 
reactions with methanol to give the corresponding 
carboxylic acid esters. Benzothietone dimerizes, 
trimerizes and polymerizes and the polymer is by 
far the major product (Scheme V)40. 
iii. A series of benzisothiazole-3-carboxamides have 
prepared and tested for potential antipsychotic 
activity. In general, the compounds showed an 
affinity for dopamine D2 and serotonin 5 HT2A 
and 5HT1A receptors (Scheme VI)41. 
iv. Cyclic secondary α-amino acids react with  














azomethine ylide formation and subsequent 
cycloaddition involving an endo transition  
state to give cycloadducts in 67-82% yield 
(Scheme VII)42. 
v. Thioisatin reacts with malononitrile in the 
presence of triethylamine with ring expansion to 
yield thiocoumarin. In the absence of 
triethylamine, the reaction yields condensation 
product without ring opening (Scheme VIII)43. 
vi. 2,3-Thianaphthene-quinones were successively 
converted to thianahthene-2, 3-dicarboxylic acids, 
their imides, diamides and finally thianaphthene-
2, 3-dicarbonitriles the key precursors for series 
of novel porphyrazines bearing four 2, 3-
annulated thianaphthene moieties (Scheme IX)44. 
vii. Indigo and a number of indigoid dyes belonging 
to the indole or thionaphthene series are more or 
less readily decomposed by alkalies in o-H2N-
C6H4-COOH or HS-C6H4COOH and a cyclic o-
hydroxy aldehyde (Scheme X). 
viii. Verma et al.45 have accomplished a simple and 
efficient method for the synthesis of novel 
spiropyrrolidines by regioselective 1,3-dipolar 
cycloaddition reactions of azomethine ylide 
generated by benzo[b]thiophene-2,3-dione and 
piperidine 2-carboxylic acid in good yield 
(Scheme XI). 
ix. R. T. Pardasani et al.46 have revealed a [3+2] 
cycloaddition reactions of cyclic secondary α-
amino acids viz. L-proline and (R)-(−)-thiaproline 
with 5-methylthioisatin via azomethine ylide in 
the presence of dipolarophiles afford 
azabicyclooctane derivatives in moderate-to-good 
yields (Scheme XII). 
x. Condensation of benzo[b]thiophene-2,3-diones 
with o-phenylenediamines have been reported to 
give thionaphthaphenazines (10) whereas, non-o-
phenylenediamines react with thioisatin to give 
(11)47. 
xi. Recently J. George, et al.48 have accomplished a 
simple and efficient method for the synthesis of 
novel spirothiazolidinones by nucleophilic 
cyclocondensation of intermediate imine with 
mercaptoacetic acid is described. Computational 
studies have been performed to substantiate the 
proposed mechanism as well as to ascertain 
transition state of the system. 
The entire reaction was carried out by the use of 
“Dean Stark Apparatus” and theoretical amount of 
water was removed azeotropically. The crude  
product was purified by column chromatography on 
silica gel with petroleum ether: chloroform (1:1) in 
54-68% yield. 
 
Synthesis and reactions of disulfides derivatives 
Curt Wentrup, Harald Bender and Gerhard Gross49 
reported the synthesis of benzothiet-2-one in nearly 
quantitative yield (94%) as a pale-yellow solid by 
flash vacuum pyrolysis (FVP) of benzothiophene -2, 
3-dione at 650°C. The product is isolated on a cold 
finger cooled with liquid nitrogen. Benzothietone 

















o-mercaptobenzoate (12) in 85% isolated yield.  
The thiol (13) is completely oxidized to the disulfide 
(14) by prolonged stirring in the presence of air 
(Scheme XIII, Scheme IV). 
 
Cleavage of C-S bond 
When thioisatin derivatives were treated with 
alkali, cleavage of C-S bond occurs to form 2-
mercaptophenyl glyoxalic acid which on treatment 
with chloroacetic acid in the presence of a base gives 
thiophenic dicarboxylic acid (Scheme XV)50. 
Oxidation will take place when benzo[b]thiophene-
2, 3-diones treated with hydrogen peroxide and 
ammonia to afford 1, 2-benzoisothiazoles51. But, 
when oxidation is carried out with hydrazoic acid in 
sulphuric acid a dimer is formed from thioisatin. 
Benzo[b]thiophene undergoes ring opening and 
subsequent cyclization with ethyl cyanoacetate to give 
thiocoumarin derivatives which takes place in the 
presence of triethylamine52. 
Disulfide dimmer compounds53 were synthesized 
by the treatment of thioisatin with diethylamine at 
80°C for 3hr in nonpolar dry toluene (Scheme XVI) 
and kept at RT in open environment for one night. 
After trapping the solvent, rectangular shaped crystals 
were formed by air oxidation in high yield (72-75%) 
and purity (Figure 2). 
 




Cyclobutane54, oxetanes55 and thietanes56,57  
are synthesis by photo-cycloaddition of benzo[b] 
thiophene-2,3-diones to C=C, C=O and C=S bonds 
respectively to yield four membered cycles. However  
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Scheme XIII — Mechanistic pathway for the formation of spirothiazolidinones 
 





similar [4+2] photocyclodddtions reactions with other 
olefins are less common. Examples are persented 
below. 
Dioxene derivatives have been synthesized by 
photochemical reactions of benzo[b]thiophene-2,3-
diones with 2, 3-dimethylbut-2-ene gave in excellent 
yields (Scheme XVII)58. 
Benzo[b]thiophene-2,3-dione with electron-rich 
and electron deficient alkenes have been described as 
[4+2] Photocycloadditions. Olefines preferentially 
add at both carbonyl groups to give the head-to- 
head [4+2] cycloadducts, i.e., dioxanes only  
(Scheme XVIII)59. 
Syntheses of 3-(phenyl)-benzo[b]thiophene [2, 3-
d][1,2] benzodiazocine derivatives60 have been 
accomplished by the reaction of 3-phenacylidine-2-
benzo[b]thiophene-2-ones with o-phenylene diamine. 
The photolytic reaction with trans-stilbene resulted in 
















Figure 2 — An ORTEP view of the molecule of compound 
15 with atom numbering. Displacement ellipsoids are drawn 








(Scheme XIX). Theoretical calculations have been 
performed to study the mechanism and 
stereoselectivity of products. Good yield and broad 
scope of usable substrates of industrial relevance are 
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